199 related articles for article (PubMed ID: 2476268)
21. Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sjögren's syndrome.
Zeher M; Szodoray P; Gyimesi E; Szondy Z
Arthritis Rheum; 1999 Aug; 42(8):1673-81. PubMed ID: 10446867
[TBL] [Abstract][Full Text] [Related]
22. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
Kobayashi M; Yasui N; Ishimaru N; Arakaki R; Hayashi Y
Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
[TBL] [Abstract][Full Text] [Related]
23. Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndrome.
Kobayashi M; Kawano S; Hatachi S; Kurimoto C; Okazaki T; Iwai Y; Honjo T; Tanaka Y; Minato N; Komori T; Maeda S; Kumagai S
J Rheumatol; 2005 Nov; 32(11):2156-63. PubMed ID: 16265694
[TBL] [Abstract][Full Text] [Related]
24. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
[TBL] [Abstract][Full Text] [Related]
25. Effect of gold therapy on CD5+ B-cells and TCR gamma delta+ T-cells in patients with rheumatoid arthritis.
Hassan J; Feighery C; Bresnihan B; Whelan A
Rheumatol Int; 1991; 11(4-5):175-8. PubMed ID: 1723811
[TBL] [Abstract][Full Text] [Related]
26. Expression of CD5 and CD72 on T and B cell subsets in rheumatoid arthritis and Sjögren's syndrome.
Jamin C; Lamour A; Pennec YL; Hirn M; Le Goff P; Youinou P
Clin Exp Immunol; 1993 May; 92(2):245-50. PubMed ID: 7683586
[TBL] [Abstract][Full Text] [Related]
27. Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies.
Adamson TC; Fox RI; Frisman DM; Howell FV
J Immunol; 1983 Jan; 130(1):203-8. PubMed ID: 6600176
[TBL] [Abstract][Full Text] [Related]
28. Ex vivo CD(+) T-cell cytokine expression from patients with Sjögren's syndrome following in vitro stimulation to induce proliferation.
Koarada S; Haruta Y; Mitamura M; Morito F; Tada Y; Ohta A; Nagasawa K
Rheumatology (Oxford); 2006 Apr; 45(4):392-9. PubMed ID: 16287915
[TBL] [Abstract][Full Text] [Related]
29. T cell receptor expression in Sjögren's syndrome.
Zumla A; Mathur M; Stewart J; Wilkinson L; Isenberg D
Ann Rheum Dis; 1991 Oct; 50(10):691-3. PubMed ID: 1720300
[TBL] [Abstract][Full Text] [Related]
30. BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sjögren's syndrome.
d'Arbonneau F; Pers JO; Devauchelle V; Pennec Y; Saraux A; Youinou P
Arthritis Rheum; 2006 Jan; 54(1):115-26. PubMed ID: 16385503
[TBL] [Abstract][Full Text] [Related]
31. The expression and function of CD3 and CD5 in patients with primary Sjögren's syndrome.
Dauphinée MJ; Tovar Z; Ballester A; Talal N
Arthritis Rheum; 1989 Apr; 32(4):420-9. PubMed ID: 2468337
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemistry of the B-cell component in lower lip salivary glands of Sjögren's syndrome and healthy subjects.
Larsson A; Bredberg A; Henriksson G; Manthorpe R; Sallmyr A
Scand J Immunol; 2005 Jan; 61(1):98-107. PubMed ID: 15644129
[TBL] [Abstract][Full Text] [Related]
33. Abnormal B cell differentiation in primary Sjögren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with Serum IgG concentration.
Bohnhorst JØ; Bjørgan MB; Thoen JE; Jonsson R; Natvig JB; Thompson KM
Clin Immunol; 2002 Apr; 103(1):79-88. PubMed ID: 11987988
[TBL] [Abstract][Full Text] [Related]
34. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases.
Kojo S; Adachi Y; Keino H; Taniguchi M; Sumida T
Arthritis Rheum; 2001 May; 44(5):1127-38. PubMed ID: 11352245
[TBL] [Abstract][Full Text] [Related]
35. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome.
Hansen A; Odendahl M; Reiter K; Jacobi AM; Feist E; Scholze J; Burmester GR; Lipsky PE; Dörner T
Arthritis Rheum; 2002 Aug; 46(8):2160-71. PubMed ID: 12209521
[TBL] [Abstract][Full Text] [Related]
36. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
[TBL] [Abstract][Full Text] [Related]
37. Association between HLA-DRB1*15 and secondary Sjögren's syndrome in patients with rheumatoid arthritis.
Mattey DL; González-Gay MA; Hajeer AH; Dababneh A; Thomson W; García-Porrúa C; Ollier WE
J Rheumatol; 2000 Nov; 27(11):2611-6. PubMed ID: 11093441
[TBL] [Abstract][Full Text] [Related]
38. Lymphopenia in Sjögren's syndrome with rheumatoid arthritis: relationship to lymphocytotoxic antibodies, cryoglobulinemia, and impaired mitogen responsiveness.
Utsinger PD; Yount WJ
J Rheumatol; 1976 Dec; 3(4):355-66. PubMed ID: 1088165
[TBL] [Abstract][Full Text] [Related]
39. CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis.
Smith HR; Olson RR
J Rheumatol; 1990 Jun; 17(6):833-5. PubMed ID: 1696993
[TBL] [Abstract][Full Text] [Related]
40. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J
Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
